Selected article for: "disease severity and MERS cov"

Author: Alshukairi, Abeer N.; Zhao, Jincun; Al-Mozaini, Maha A.; Wang, Yanqun; Dada, Ashraf; Baharoon, Salim A.; Alfaraj, Sara; Ahmed, Waleed A.; Enani, Mushira A.; Elzein, Fatehi E.; Eltayeb, Nazik; Layqah, Laila; El-Saed, Aiman; Bahaudden, Husam A.; Haseeb, Abdul; El-Kafrawy, Sherif A.; Hassan, Ahmed M.; Siddiq, Najlaa A.; Alsharif, Ibtihaj; Qushmaq, Isamel; Azhar, Esam I.; Perlman, Stanley; Memish, Ziad A.
Title: Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia
  • Cord-id: z1uz0awb
  • Document date: 2021_5_25
  • ID: z1uz0awb
    Snippet: Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV–specific neutralizing antibodies were detected for 6 years postinfection.
    Document: Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV–specific neutralizing antibodies were detected for 6 years postinfection.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1
    Co phrase search for related documents, hyperlinks ordered by date